Cover Image

Prognosis and Predictive Factors Related to Breast Cancer

Ezatollah Aalipour, Ehsan Jangholi

 

 

 

Breast Cancer; Prognosis; Estrogen Receptor; Progesterone Receptor; Human Epidermal Growth Factor Receptor-2

Mirmalek SA, Azizi MA, Jangholi E, Yadollah-Damavandi S, Javidi MA, Parsa Y, et al. Cytotoxic and apoptogenic effect of hypericin, the bioactive component of Hypericum perforatum on the MCF-7 human breast cancer cell line. Cancer Cell Int. 2015; 16: 3.

Mirmalek S, Jangholi E, Jafari M, Yadollah-Damavandi S, Javidi M, Parsa Y, et al. Comparison of in Vitro Cytotoxicity and Apoptogenic Activity of Magnesium Chloride and Cisplatin as Conventional Chemotherapeutic Agents in the MCF-7 Cell Line. Asian Pac J Cancer Prev. 2016;17 Spec No.:131-4.

Shokouh TZ, Ezatollah A, Barand P. Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: Retrospective-Observational Analytical Study. Medicine. 2015;94(32):e1359.

Taghavi A, Fazeli Z, Vahedi M, Baghestani A, Pourhoseingholi A, Barzegar F, et al. Increased trend of breast cancer mortality in Iran. Asian Pacific journal of cancer prevention: Asian Pac J Cancer Prev. 2012;13(1):367-70.

Moutafoff C, Coutant C, Bezu C, Antoine M, Werkoff G, Benbara A, et al. Prognostic and predictive factors in multifocal breast carcinoma. Gynecol Obstet Fertil. 2011;39(7-8):425-32. [In French]

Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma. Breast J. 2005;11(4):278-80.

Mahmood H, Faheem M, Mahmood S, Sadiq M, Irfan J. Impact of age, tumor size, lymph node metastasis, stage, receptor status and menopausal status on overall survival of breast cancer patients in Pakistan. Asian Pac J Cancer Prev. 2015;16(3):1019-24.

Mirmalek SA, Elhamkani F, Tabatabaee SAS, Mahmoodzadeh H, Parsa Y, Yadollah-Damavandi S, et al. Introduction of HER-2 and a Short Review on Its Role in Prognosis and Treatment of Breast Cancer. GMJ. 2014;3(3):132-44.

Mirmalek SA, Kani FE, Mehrabi A, Chavoshi-Nejad M, Salimi-Tabatabaee SA, Parsa Y, et al. Breast Carcinoma; Human Epidermal Growth Factor Receptor-2 (HER-2) and Grading Correlation. IJTMGH. 2015;3(3):95-7.

Parsa Y, Mirmalek SA, Elham Kani F, Aidun A, Salimi-Tabatabaee SA, Yadollah-Damavandi S, et al. A Review of the Clinical Implications of Breast Cancer Biology. Electronic Physician. 2016; 8(5):2416-24.

Hahrel R, Woodings T, Vivian AB. Prognostic Value of estrogen receptors in primary breast Cancer. Cancer. 1979;44(2):671-5.

Akbar M, Akbar K, Naveed D. Frequency and correlation of molecular subtypes of breast cancer with clinicopathological features. J Ayub Med Coll Abbottabad. 2014;26: 290-3.

Salmen J, Neugebauer J, Fasching PA, Haeberle L, Huober J, Wockel A, et al. Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studies. Breast Cancer Res Treat. 2014;148(1):143-51.

Mirmalek SA, Hajilou M, Salimi Tabatabaee SA, Parsa Y, Yadollah-Damavandi S, Parsa T. Prevalence of HER-2 and Hormone Receptors and P53 Mutations in the Pathologic Specimens of Breast Cancer Patients. Int J Breast Cancer. 2014; 2014: 564308.

Bae SY, Choi MY, Cho DH, Lee JE, Nam SJ, Yang JH. Mucinous carcinoma of the breast in comparison with invasive ductal carcinoma: clinicopathologic characteristics and prognosis. J Breast Cancer. 2011;14(4):308-13.

Kim HW, Lee HM, Hwang SH, Ahn SG, Lee KA, Jeong J. Patterns and Biologic Features of p53 Mutation Types in Korean Breast Cancer Patients. J Breast Cancer. 2014;17(1):1-7.

Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer. 2005;93(9):1046-52.

De Potter C. The neu-oncogene: more than a prognostic indicator? Human pathology. 1994;25(12):1264-8.

Rodrigues NA, Dillon D, Carter D, Parisot N, Haffty BG. Differences in the pathologic and molecular features of in tra ductal breast carcinoma between younger and older women. Cancer. 2003;97(6):1393-403.

Wang B, Wang X, Wang J, Xuan L, Wang Z, Wang X, et al. Expression of Ki67 and clinicopathological features in breast cancer. Zhonghua Zhong Liu Za Zhi. 2014;36(4):273-5. [In Chines]

Mai GF, Zheng H, Luo RC, Liao WJ, Zhang LS, He XB. Association of progesterone receptor and HER2 expressions with the survival time of patient with breast cancer. Di Yi Jun Yi Da Xue Xue Bao. 2003;23(4):372-4.

Refbacks

  • There are currently no refbacks.